期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌骨转移治疗的若干热点问题思考和讨论：乳腺癌骨转移和骨相关疾病临床诊疗专家共识（2014版）解读 被引量：15

Some hot issues in the treatment of bone metastasis of breast cancer： interpretation of Expert Consensus on the Diagnosis and Treatment of Bone Metastasis and Skeletal Related Diseases in Breast Cancer （2014 version）
原文传递
导出
摘要 乳腺癌是女性最常见的恶性肿瘤，骨转移引起的骨痛、病理性骨折等骨相关事件可严重影响患者的生命质量。2014年中国抗癌协会乳腺癌专业委员会组织相关专家再次讨论制定了“乳腺癌骨转移和骨相关疾病临床诊疗专家共识（2014版）”，文章对其中若干热点问题进行一些思考及探讨。 Breast cancer is the most common malignant tumor in women, bone related events （SREs）, such as bone pain, pathological fracture and so on, can affect seriously the quality of life. Experts in Chinese Anti-Cancer Association, Committee of Breast Cancer Society （CACA-CBCS） discussed the Consensus on the Diagnosis and Treatment of Bone Metastasis and Skeletal Related Diseases in Breast Cancer （ 2014 version ）, here reflections on several hot issues were explored.
作者 王如良 江泽飞
机构地区 军事医学科学院附属医院乳腺肿瘤内科
出处 《肿瘤研究与临床》 CAS 2015年第10期707-710,共4页 Cancer Research and Clinic
关键词 乳腺肿瘤 骨转移 共识 Breast neoplasms Bone Metastasis Consensus
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献30

  • 1Coleman RE. Metastatic bone disease : clinical features, pathophysiology and treatment strategies [ J ]. Cancer Treat Rev, 2001,27(3) :165-176.
  • 2Johnson JR,Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs [ J ]. J Clin Oncol, 2003,21 (7) :1404-1411.
  • 3Kinnane N. Burden of bone disease [ J ]. Eur J Oncol Nurs, 2007, 11 ( Suppl 2 ) : $28-$31.
  • 4Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging[ J]. Semin Nucl Med,2005, 35(2) :84-99.
  • 5Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases : a systematic review [ J ]. J Clin Oncol,2007,25 ( 11 ) : 1423-1436.
  • 6British Association of Surgical Oncology Guidelines. The management of metastatic bone disease in the United Kingdom. The Breast Specialty Group of the British Association of Surgical Oneology[ J]. Eur J Surg Oncol, 1999,25 (1) :3-23.
  • 7WHO. Medical need for opioid analgesics. Achieving balance in national opioids control policy: Guidelines for assessment [ R ]. Geneva: WHO Publication,2000 : 3-4.
  • 8Russell RG. Bisphosphonates: from bench to bedside[ J]. Ann N Y Aead Sei, 2006,1068:367-401.
  • 9Russell RG, Xia Z, Dunford JE, et al. Bisphosphonates : an update on mechanisms of action and how these relate to clinical efficacy[ J ]. Ann N Y Acad Sci,2007,1117 : 209 -257.
  • 10Weitzman R,Sauter N,Eriksen EF,et al. Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients-May 2006 [ J]. Crit Rev Oncol Hemato1,2007,62 ( 2 ) : 148 -152.

共引文献571

同被引文献142

  • 1孙海燕,方呈祥.WB-DWI对恶性肿瘤检测价值探讨[J].中国医学前沿杂志（电子版）,2014,6(4):97-99. 被引量：1
  • 2刘华,曾柏荣,许利纯.加味八珍汤配合化疗治疗晚期胃癌疗效观察[J].现代中西医结合杂志,2006,15(24):3366-3366. 被引量：11
  • 3顾晓鸣,陆群,沈伟.运用Excel“随机数发生器”进行随机化分组[J].中国医院统计,2007,14(3):287-288. 被引量：12
  • 4Smith MR, Saad F, Coleman R, et al. Denosumab and bone- metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet, 2012, 379(9810): 39-46.
  • 5Ruggiero SL, Dodson TB, Famasia 5, et aL American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg, 2014,72(10): 1938-1956.
  • 6Ross JR, Saunders Y, Edmonds PM, et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ, 2003, 327(7413): 469.
  • 7Hatoum HT, Lin SJ, Smith MR, et al. Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims database. Cancer, 2008, 113(6): 1438-1445.
  • 8Fusco V, Bedogni A, Campisi G. Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab. Support Care Cancer, 2014, 22 (7): 1737-1738.
  • 9Beuselinck B, Woher P, Karadimou A, et al. Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases. Br J Cancer, 2012, 107(10): 1665-1671.
  • 10Fusco V, Porta C, Saia G, et al. Osteonecrosis of the jaw in patients with metastatic renal cell cancer treated with bisphosphonates and targeted agents: results of an italian muhicenter study and review of the literature. Clin Genitourin Cancer, 2015, 13(4): 287-294.

引证文献15

二级引证文献95

肿瘤研究与临床
2015年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部